Literature DB >> 29436280

Clinicopathologic Characteristics and Survival Outcomes in Floor of Mouth Squamous Cell Carcinoma: A Population-Based Study.

Satvir Saggi1, Karam W Badran1, Albert Y Han1, Edward C Kuan1, Maie A St John1,2.   

Abstract

Objective To describe the determinants of survival for patients with floor of mouth (FOM) squamous cell carcinoma (SCC) from 1973 to 2013 with the SEER database (Surveillance, Epidemiology, and End Results). Study Design and Setting Retrospective cohort study with a national database. Subjects and Methods The SEER registry was utilized to calculate survival trends for patients with FOM SCC between 1973 and 2013. Patient data were analyzed with respect to age, sex, race, primary site, stage at presentation, tumor size, grade, and treatment modalities (surgery and radiotherapy). Overall survival (OS) and disease-specific survival (DSS) were calculated. Results A total of 14,010 FOM SCC cases were identified. The cohort was 69.5% male, and the median age at diagnosis was 62 years. Forty-six percent of cases were treated with surgery, while 14% received radiotherapy. Kaplan-Meier analysis demonstrated OS and DSS of 39% and 59% at 5 years, respectively. Multivariate analysis showed that age, grade, stage, size, and surgery were determinants for OS and DSS (all P < .05). For early- and advanced-stage cancers, age, grade, size, and surgery predicted OS and DSS, while radiotherapy was a predictor of OS and DSS in advanced-stage tumors only (all P < .05). Conclusion To our knowledge, this study is the largest to date investigating prognostic factors for survival of patients diagnosed with FOM SCC. Determinants of survival include age, grade, stage, size, and surgery. Surgery appears to play a critical role in the management of these tumors.

Entities:  

Keywords:  floor of mouth cancer; head and neck cancer; population-based study; squamous cell carcinoma

Mesh:

Year:  2018        PMID: 29436280     DOI: 10.1177/0194599818756815

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Survival outcomes after treatment of cancer of the oral cavity (1985-2015).

Authors:  Daniella Karassawa Zanoni; Pablo H Montero; Jocelyn C Migliacci; Jatin P Shah; Richard J Wong; Ian Ganly; Snehal G Patel
Journal:  Oral Oncol       Date:  2019-02-15       Impact factor: 5.337

2.  Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques.

Authors:  Tae Hyung Kim; In-Ho Cha; Eun Chang Choi; Hye Ryun Kim; Hyung Jun Kim; Se-Heon Kim; Ki Chang Keum; Chang Geol Lee
Journal:  Front Oncol       Date:  2021-03-12       Impact factor: 6.244

3.  Sarcomatoid carcinoma after radiotherapy for early-stage oral squamous cell carcinoma: Case report.

Authors:  Bo Young Kim; Kyoung Rai Cho; Jung Heob Sohn; Jung Yeon Kim
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost.

Authors:  Tomáš Blažek; Zuzana Zděblová Čermáková; Lukáš Knybel; Pavel Hurník; Jan Štembírek; Kamila Resová; Tereza Paračková; Martin Formánek; Jakub Cvek; Renata Soumarová
Journal:  Radiat Oncol       Date:  2021-06-29       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.